Related Experiment Videos
Current concepts of Behçet's disease
Summary
Fibrinolytic agents show promise for treating Behçet
Area of Science:
- Rheumatology
- Immunology
- Hematology
Background:
- Behçet's disease is a complex systemic vasculitis with unclear etiology.
- Current management strategies for Behçet's disease present significant challenges.
Observation:
- Clinical assessment and immune status investigations were performed on seven Behçet's disease patients.
- Microscopic examination of an affected eye revealed immune vasculitis and venous clot formation.
Findings:
- All patients received fibrinolytic agent therapy.
- Favorable clinical responses were observed in patients treated with fibrinolytic agents.
Implications:
- Fibrinolytic therapy may represent a primary treatment option for Behçet's disease.
- Further research into fibrinolytic agents for Behçet's disease is warranted.